Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | LMNA | P02545 | 2/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.74 |
| ▸ | MAOA | P21397 | 2/20 | 0.74 |
| ▸ | IDO1 | P14902 | 2/20 | 0.74 |
| ▸ | MAOB | P27338 | 2/20 | 0.74 |
| ▸ | NPC1 | O15118 | 1/20 | 0.74 |
| ▸ | KDM1A | O60341 | 1/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.74 |
| ▸ | HTR1A | P08908 | 1/20 | 0.74 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.74 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.74 |
| ▸ | TSHR | P16473 | 1/20 | 0.74 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.74 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.74 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.74 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6268383 | 0.98 | CYP3A4 (0.71) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| Hydrochloric Acid SCHEMBL11528823 | 0.98 | CYP3A4 (0.71) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| SCHEMBL7065369 | 0.93 | MAOB (0.71) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| SCHEMBL29263705 | 0.91 | SIGMAR1 (0.69) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| Hydrochloric Acid SCHEMBL7060935 | 0.91 | CYP3A4 (0.68) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| Hydrochloric Acid SCHEMBL17064267 | 0.91 | CYP3A4 (0.68) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| SCHEMBL8861460 | 0.91 | SIGMAR1 (0.69) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| Phenelzine SCHEMBL3644150 | 0.85 | LMNA (1.00) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| Phenelzine SCHEMBL34335 | 0.85 | LMNA (1.00) | ALDH1A1LMNACYP3A4MAOAIDO1 | |
| Butylbenzyl SCHEMBL28088961 | 0.84 | SIGMAR1 (0.62) | ALDH1A1LMNACYP3A4MAOAIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119836205-A | Perovskite solar cell based on multifunctional additive and preparation method thereof | 东方电气长三角(杭州)创新研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-114437153-A | Adriamycin-monoamine oxidase inhibitor prodrug compound and preparation method and application thereof | 沈阳药科大学 | 2022-05-06 | — | — | CN | claimed |
| US-5985512-A | BASE RESIN, PHOTOACID GENERATOR, SOLVENT AND NITRONENOUS ORGANIC COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1999-11-16 | — | — | US | claimed |
| US-4786653-A | Treatment of neurotransmitter-linked drug abuse | GOLWYN DANIEL H (US) | 1988-11-22 | — | — | US | claimed |
| JP-5246970-A | — | — | None | — | — | JP | disclosed |
| CN-119836205-A | Perovskite solar cell based on multifunctional additive and preparation method thereof | 东方电气长三角(杭州)创新研究院有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-114437153-B | Adriamycin-monoamine oxidase inhibitor prodrug compound and preparation method and application thereof | 沈阳药科大学 | 2023-10-27 | — | — | CN | disclosed |
| WO-2015080665-A1 | CHALCONE-UREA DERIVATIVES AS INSULIN SENSORS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-06-04 | — | — | WO | disclosed |
| CN-102405211-B | Proline derivatives as cathepsin inhibitors | HOFFMANN LA ROCHE | 2015-01-21 | — | — | CN | disclosed |
| EP-2421826-B1 | PROLINE DERIVATIVES AS CATHEPSIN INHIBITORS | HOFFMANN LA ROCHE (CH) | 2013-10-23 | — | — | EP | disclosed |
| US-8163793-B2 | Proline derivatives | HOFFMAN-LA ROCHE INC. (US) | 2012-04-24 | — | — | US | disclosed |
| CN-102405211-A | Proline derivatives as cathepsin inhibitors | HOFFMANN LA ROCHE | 2012-04-04 | — | — | CN | disclosed |
| US-5229417-A | Obsessive compulsive disorders | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-07-20 | — | — | US | disclosed |
| US-5229417-A | Obsessive compulsive disorders | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-07-20 | — | — | US | disclosed |
| US-5229417-A | Obsessive compulsive disorders | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-07-20 | — | — | US | disclosed |
| EP-0545425-A1 | 2-(3-Phenylpropyl)hydrazines, intermediates in and a process for the preparation thereof, and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-06-09 | — | — | EP | disclosed |
| US-4919808-A | Semipermeable membrane compositions | ALLIED-SIGNAL INC. (US) | 1990-04-24 | — | — | US | disclosed |
| US-4919916-A | Treatment of neurotransmitter-linked drug abuse | GOLWYN DANIEL H (US) | 1990-04-24 | — | — | US | disclosed |
| US-4786653-A | Treatment of neurotransmitter-linked drug abuse | GOLWYN DANIEL H (US) | 1988-11-22 | — | — | US | disclosed |
| US-4639441-A | ANTIBACTERIAL PENICILLINS | SANKYO COMPANY LIMITED (JP) | 1987-01-27 | — | — | US | disclosed |